# Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder

> **NCT06839326** · NA · COMPLETED · sponsor: **Batman University** · enrollment: 75 (actual)

## Conditions studied

- Temporomandibular Joint Osteoarthritis

## Interventions

- **BIOLOGICAL:** Autologous Conditioned Serum, Genesis Biyomedikal, Sanakin®-Acrs produce
- **BIOLOGICAL:** Platelet Rich Plasma
- **OTHER:** Control Group/ Only Arthrocentesis

## Key facts

- **NCT ID:** NCT06839326
- **Lead sponsor:** Batman University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06839326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06839326, "Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06839326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*